Crow T J
Ciba Found Symp. 1979(69):335-43. doi: 10.1002/9780470720523.ch20.
The diagnosis of schizophrenia is established principally by the presence of certain psychological symptoms which although subjective can be reliably assessed by standardized interviewing procedures. The most characteristic symptoms (Schneider's first-rank symptoms) fall into three groups: (a) auditory hallucinations of particular types, (b) 'ego-boundary disturbances', including intrusions into the stream of consciousness attributed to external agencies, and (c) delusional perception. Symptoms closely resembling those seen in schizophrenia can be induced in non-schizophrenic individuals by amphetamine-like drugs, and both these symptoms and those of schizophrenia are ameliorated by neuroleptic drugs (the major tranquillizers). Amphetamines facilitate and neuroleptic drugs diminish neural transmission mediated by the chemical substance dopamine. In recent post-mortem studies on patients who had suffered brom schizophrenia, it was found that dopamine release was not increased. However, in some cases there was evidence of increased sensitivity of the dopamine receptor.
精神分裂症的诊断主要依据某些心理症状的存在,这些症状虽然是主观的,但可以通过标准化的访谈程序进行可靠评估。最具特征性的症状(施奈德首级症状)分为三组:(a)特定类型的幻听,(b)“自我边界障碍”,包括归因于外部因素的意识流侵扰,以及(c)妄想性知觉。类似精神分裂症症状的症状可由苯丙胺类药物在非精神分裂症个体中诱发,并且这些症状和精神分裂症的症状都可被抗精神病药物(主要的镇静剂)改善。苯丙胺促进而抗精神病药物减少由化学物质多巴胺介导的神经传递。在最近对患溴精神分裂症患者的尸检研究中,发现多巴胺释放并未增加。然而,在某些情况下,有证据表明多巴胺受体敏感性增加。